Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis

被引:144
作者
Febbraio, M
Guy, E
Silverstein, RL
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA
[2] Cornell Univ, Weill MEd Coll, Dept Med, Div Hematol Med Oncol, New York, NY USA
关键词
CD36; atherosclerosis; Apo E-null mice; scavenger receptor; macrophages;
D O I
10.1161/01.ATV.0000148007.06370.68
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - CD36 is expressed on multiple cell types and has numerous functions, a subset of which can impact on atherogenesis. In previous work, we demonstrated that CD36 absence was protective against lesion formation. The current objective was to determine whether absence of macrophage CD36 alone was protective. Methods and Results - Lethal irradiation and stem cell transfer were used to create chimeric mice that did or did not express macrophage CD36 in the context of the Apo E-null model of atherosclerosis. After engraftment, mice were fed a Western diet for 12 weeks. White cell counts, plasma levels of lipoproteins, triacylglycerol, and nonesterified fatty acids were determined, and glucose tolerance tests were preformed. Lesion area was assessed quantitatively after oil red O staining. Mice lacking CD36 in macrophages alone were profoundly protected against atherosclerosis (88.1% reduction of lesion area throughout the aortic tree). Re-introduction of macrophage CD36 resulted in a 2.11-fold increase in lesion area. There were no differences in engraftment, macrophage recruitment, glucose tolerance, weight, and total, low-density lipoprotein, and high-density lipoprotein cholesterol among the groups. Lesions contained similar percent macrophage antigen-positive area. Conclusion - Protection in this model is primarily caused by loss of CD36 macrophage function.
引用
收藏
页码:2333 / 2338
页数:6
相关论文
共 32 条
[1]   Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation [J].
Blanquart, C ;
Barbier, O ;
Fruchart, JC ;
Staels, B ;
Glineur, C .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 85 (2-5) :267-273
[2]   HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages [J].
Dressman, J ;
Kincer, J ;
Matveev, SV ;
Guo, L ;
Greenberg, RN ;
Guerin, T ;
Meade, D ;
Li, XA ;
Zhu, WF ;
Uittenbogaard, A ;
Wilson, ME ;
Smart, EJ .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03) :389-397
[3]   CD36 mediates the innate host response to β-amyloid [J].
El Khoury, JB ;
Moore, KJ ;
Means, TK ;
Leung, J ;
Terada, K ;
Toft, M ;
Freeman, MW ;
Luster, AD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) :1657-1666
[4]  
ElKhoury J, 1996, NATURE, V382, P716
[5]  
ENDEMANN G, 1993, J BIOL CHEM, V268, P11811
[6]   Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice [J].
Febbraio, M ;
Podrez, EA ;
Smith, JD ;
Hajjar, DP ;
Hazen, SL ;
Hoff, HF ;
Sharma, K ;
Silverstein, RL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1049-1056
[7]  
Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006
[8]   Variability of the CD36 gene in West Africa [J].
Gelhaus, A ;
Scheding, A ;
Browne, E ;
Burchard, GD ;
Horstmann, RD .
HUMAN MUTATION, 2001, 18 (05) :444-450
[9]   Transforming growth factor-β1 (TGF-β1) and TGF-β2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-γ [J].
Han, JH ;
Hajjar, DP ;
Tauras, JM ;
Feng, JW ;
Gotto, AM ;
Nicholson, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :1241-1246
[10]  
Han JH, 1999, J LIPID RES, V40, P830